Sylvain Pilorge

Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Domenico Russo, Michael Henry Schmitt, Sylvain Pilorge et al. · The Lancet Haematology · 2023 · 82 citations

Cell Therapy, Cytomegalovirus Infection, Transplantation +5

Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index

Clémentine Sarkozy, Christine Terré, Fabrice Jardin et al. · Genes Chromosomes and Cancer · 2013 · 64 citations · Full text

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

Jordan Gauthier, Xavier Poiré, Anne‐Claire Gac et al. · Bone Marrow Transplantation · 2018 · 43 citations · Full text

Transplantation, Marrow Transplantation, Medicine +10

Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification

Meir Wetzler, Krzysztof Mrózek, Jessica Kohlschmidt et al. · Haematologica · 2013 · 41 citations · Full text

Intensive Induction, Molecular Markers, Genetics +16

Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse

Sylvain Pilorge, Sophie Rigaudeau, Florence Rabian et al. · American Journal of Hematology · 2013 · 26 citations · Full text